Adelebsen, Germany

Marc Hogreve

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Adelebsen, DE (2016 - 2024)
  • Göttingen, DE (2024)

Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Inventor Marc Hogreve – Innovations in Biopharmaceutical Integrity Testing

Introduction

Marc Hogreve, an accomplished inventor based in Adelebsen, Germany, has made significant contributions to the field of biopharmaceutical products through his innovative inventions. With a total of nine patents to his name, he has developed advanced technologies that enhance the integrity testing of flexible containers used for biopharmaceutical applications.

Latest Patents

Among Marc's latest patents is a sophisticated sealing device and method for detecting potential gas leaks at fitting connections for biopharmaceutical products. This sealing arrangement incorporates a connecting device and housing parts to effectively enclose an attachment component that forms the head of the device. The gas-permeable end is designed to be isolated, enabling the detection of gases within a hermetically sealed chamber. The innovative sealing structure ensures tight radial contact around the connecting device, facilitating integrity testing of the hose end at a barbed nozzle.

Another notable patent details a system and method for assessing the integrity of flexible bags used in biopharmaceutical settings. The testing system utilizes helium to identify possible leaks in the bags. By placing the bags in a vacuum chamber and connecting them to a helium feeding pipe while pre-pressurizing them with nitrogen, a thorough integrity test is conducted. The ability to detect helium partial pressure drops allows for precise identification of leaks, thereby improving the reliability of biopharmaceutical packaging.

Career Highlights

Marc has accrued invaluable experience working with prominent companies in the biopharmaceutical industry, including Sartorius Stedim FMT SAS and Sartorius Stedim Biotech GmbH. His tenure at these organizations has enabled him to apply his innovative ideas to real-world applications, resulting in patents that address critical industry challenges.

Collaborations

Throughout his career, Marc has collaborated with various professionals, including notable coworkers Laurent Thenard and Martin Dahlberg. These partnerships have not only enriched his work but have also fostered an environment of shared knowledge and innovation.

Conclusion

In summary, Marc Hogreve's contributions to the biopharmaceutical industry through his patents exemplify the important role of inventors in enhancing product integrity and safety. His innovative sealing devices and testing methods represent significant advancements that promise to improve the quality assurance processes in the biopharmaceutical field. As the industry continues to evolve, Marc's work will undoubtedly play a vital role in shaping future technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…